Physician profile
Blake E Elkins
NPI 1942465612
$976.39
in general payments reported to CMS, 2019-2025
17 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $70.84 · 2020: $45.56 · 2021: $217 · 2022: $221 · 2023: $182 · 2024: $90.20 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $422.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $190.97 | 2019-2025 | Evenity |
| Abbvie INC. | $162.01 | 2020-2023 | |
| Endo Pharmaceuticals INC. | $127.31 | 2022-2023 | Aveed |
| Endo USA, INC. | $77.78 | 2024-2025 | Aveed |
| Corcept Therapeutics | $69.45 | 2019-2025 | Korlym |
| Novo Nordisk INC | $64.54 | 2021 | |
| Insulet Corporation | $62.85 | 2024-2025 | Omnipod |
| Xeris Pharmaceuticals, INC. | $39.27 | 2022-2023 | Gvoke Hypopen |
| Averitas Pharma INC. | $31.68 | 2025 | Qutenza |
| Abbott Laboratories | $23.35 | 2021 | |
| Pfizer INC. | $22.39 | 2023 | |
| Tandem Diabetes Care, INC. | $21.97 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Merck Sharp & Dohme LLC | $21.51 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $20.44 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $15.05 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.09 | 2022 | |
| Acera Surgical, INC. | $11.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blake Elkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.